Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

USAGE OF ARITIFICIAL INTELLIGENCE IN AIDING WITH COLONIC SESSILE SERRATED LESIONS DETECTION AND DIAGNOSIS (AI-SSLD)

NCT07650344 is registered in ClinicalTrials.gov with National Healthcare Group, Singapore as lead sponsor.

NCT NCT07650344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07650344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
USAGE OF ARITIFICIAL INTELLIGENCE IN AIDING WITH COLONIC SESSILE SERRATED LESIONS DETECTION AND DIAGNOSIS (AI-SSLD)
Lead sponsor
National Healthcare Group, Singapore
Phase
Not applicable
Overall status
Recruiting
Start date
May 21, 2026
Completion date
May 3, 2027
Enrollment
628 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cade, sessile serrated lesion